Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 76
  1. Jan 09, 2026 · 11:56 · DRUG

    Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

    Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

    01
  2. Jan 09, 2026 · 08:00 · AIDR

    ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

    ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

    02
  3. Jan 08, 2026 · 22:32 · PINK

    Perimeter Medical signs deal with Intermountain Health

    Perimeter Medical signs deal with Intermountain Health

    03
  4. Jan 08, 2026 · 19:55 · CHS

    Comprehensive Healthcare Systems Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlement

    Comprehensive Healthcare Systems Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlement

    04
  5. Jan 08, 2026 · 19:04 · LOBE

    Lobe Sciences ends FY 2025 with cash of $5.85-million

    Lobe Sciences ends FY 2025 with cash of $5.85-million

    05
  6. Jan 08, 2026 · 18:00 · SKNY

    LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform

    LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform

    06
  7. Jan 08, 2026 · 17:30 · EPRX

    Eupraxia receives positive tissue data from Resolve

    Eupraxia receives positive tissue data from Resolve

    07
  8. Jan 08, 2026 · 17:30 · AIDR

    Rocket Doctor completes acquisition of Alea Health

    Rocket Doctor completes acquisition of Alea Health

    08
  9. Jan 08, 2026 · 16:28 · ASG

    Aurora Spine receives two U.S. patents

    Aurora Spine receives two U.S. patents

    09
  10. Jan 08, 2026 · 16:15 · PINK

    Perimeter Medical Imaging AI Enters Systemwide Agreement with Intermountain Health

    Perimeter Medical Imaging AI Enters Systemwide Agreement with Intermountain Health

    10
  11. Jan 08, 2026 · 10:50 · RKV

    Rakovina signs new deal with Variational AI

    Rakovina signs new deal with Variational AI

    11
  12. Jan 08, 2026 · 09:23 · ZYUS

    ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

    ZYUS Life Sciences Reports Preliminary Results from Ongoing Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

    12
  13. Jan 08, 2026 · 08:56 · LOBE

    Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

    Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy

    13
  14. Jan 08, 2026 · 08:01 · BIOV

    BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

    BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

    14
← Newer Older →